Application of fucosylation inhibitors for production of afucosylated antibody
Biotechnology Progress · 2024
DOI: 10.1002/btpr.3438 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Progress, 2024. Verfasst von Ping Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biologics Development, Global Product Development & Supply, Bristol Myers Squibb, New Brunswick, New Jersey, USA. Hauptthemen laut MEDLINE: Fucose, Cricetulus. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Fucosylation is an important quality attribute for therapeutic antibodies. Afucosylated antibodies exhibit higher therapeutic efficacies than their fucosylated counterparts through antibody‐dependent cellular cytotoxicity (ADCC) mechanism. Since higher potency is beneficial in reducing dose or duration of the treatment, afucosylated antibodies have attracted a great deal of interest in biotherapeutics development. In this study, novel small molecules GDP‐D‐Rhamnose and its derivatives (Ac‐GDP‐D‐Rhamnose and rhamnose sodium phosphate) were synthesized to inhibit the enzyme in the GDP‐fucose synthesis pathway. Addition of these compounds into cell culture increased antibody afucosylation levels in a dose‐dependent manner and had no significant impact on other protein quality attributes. A novel and effective mechanism to generate afucosylated antibody is demonstrated for biologics discovery, analytical method development, process development, and other applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biologics Development, Global Product Development & Supply, Bristol Myers Squibb, New Brunswick, New Jersey, USA.
- Chemical Process Development, Global Product Development & Supply, Bristol Myers Squibb, New Brunswick, New Jersey, USA.
ORCID-Profile: Ping Xu, Lakshmi Kandari, Anurag Khetan
Zitieren
APA
Xu, P., Ou, Y. C., Smith, M., Paulson, J., Schmidt, M. A., Kandari, L., Parsons, R., & Khetan, A. (2024). Application of fucosylation inhibitors for production of afucosylated antibody. Biotechnology Progress. https://doi.org/10.1002/btpr.3438
Vancouver
Xu P, Ou YC, Smith M, Paulson J, Schmidt MA, Kandari L, et al. Application of fucosylation inhibitors for production of afucosylated antibody. Biotechnology Progress. 2024. doi:10.1002/btpr.3438
BibTeX
@article{Xu2024,
author = {Xu, Ping and Ou, Yu Chuan and Smith, Michael and Paulson, Jim and Schmidt, Michael A and Kandari, Lakshmi and Parsons, Rodney and Khetan, Anurag},
title = {Application of fucosylation inhibitors for production of afucosylated antibody},
journal = {Biotechnology Progress},
year = {2024},
doi = {10.1002/btpr.3438}
}
EUVIMED